Jinwon Life Sciences, Foreign Investors Net Sell 29,000 Shares... Stock Price -0.76%
As of 2:31 PM on the 14th, Jinwon Life Sciences is trading at 26,000 KRW, down 0.76% from the previous day. This represents a 176.6% increase compared to August 18. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.
Today, foreigners are tentatively recorded as net sellers of 29,000 shares. Over the past five days, individual investors have net sold 107,186 shares, while foreigners and institutions have net bought 120,033 shares and 597 shares, respectively.
On September 10, Jinwon Life Sciences became a market topic with the news of an agreement to produce 100 million doses of the Inovio COVID-19 vaccine candidate.
Hot Picks Today
"You Might Regret Not Buying Now"... Overseas Retail Investors Stirred by News of Record-Breaking Monster Stocks' IPOs
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Mistaken for the Flu, Left Untreated... Death Toll Surges as WHO Declares Emergency (Comprehensive)
- "Russia Launches Large-Scale Nuclear Drills During Putin's Visit to China"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
